Eligibility criteria in sepsis-associated AKI trials preferentially exclude patients at risk to develop adverse kidney outcomes

Critical Care · Published 2026-09-23 · Journal article · DOI 10.1186/s13054-026-06348-4

Free full text

Authors (4)

Kevin Vanneck Kamdem, Fanny Vardon, Stein Silva, Stanislas Faguer

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume

30

Issue

1

Year

2026

Citation

Kamdem, K., Vardon, F., Silva, S., et al. (2026). Eligibility criteria in sepsis-associated AKI trials preferentially exclude patients at risk to develop adverse kidney outcomes. Critical Care. https://doi.org/10.1186/s13054-026-06348-4

Related articles

• Harmonizing the diagnosis of citrate accumulation - a call for standardized criteria · Critical Care · 2026 · Same journal
• Dosing of anti-infective drugs in patients undergoing therapeutic plasma exchange – considerations for practical application: a narrative review · Critical Care · 2026 · Same journal
• Fluid-intolerance signals as bedside safety limits during early septic shock resuscitation: a multicenter randomized trial · Critical Care · 2026 · Same journal
• Palliative and end-of-life care on the battlefield: a scoping review · Critical Care · 2026 · Same journal
• Increased ureagenesis revealing metabolic intolerance to enhanced nutrition in the PICU: a secondary analysis of the PEPaNIC RCT · Critical Care · 2026 · Same journal
• The evolution of ECCO₂R: rethinking pump selection · Critical Care · 2025 · Same journal
• Beyond macrocirculatory targets: a multimodal framework for microcirculatory and organ perfusion monitoring in sepsis · Critical Care · 2026 · Same journal
• Transpulmonary pressures and EIT-derived alveolar collapse and overdistension in ARDS: association and comparison of two PEEP titration strategies · Critical Care · 2026 · Same journal